TickerFactsScreenerDevelopers

SUTRO BIOPHARMA, INC. (STRO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$13.15M2017: -$37.07M2018: $12.68M2019: -$65.02M2020: -$67.80M2021: -$81.68M2022: $3.55M2023: -$111.62M2024: -$191.54M2025: -$177.23M-$177.23M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$177.23M+7.5%
2024-$191.54M-71.6%
2023-$111.62M-3245.0%
2022$3.55M+104.3%
2021-$81.68M-20.5%
2020-$67.80M-4.3%
2019-$65.02M-612.7%
2018$12.68M+134.2%
2017-$37.07M-181.9%
2016-$13.15M—